November 1st 2024
Clinicians discussed the complexities of diagnosing Long COVID, emphasizing the need for improved biomarkers and diagnostic technologies to better serve affected patients.
October 29th 2024
The CANOPY Phase 3 clinical trial demonstrated a reduced risk of symptomatic COVID-19, including a 64% reduction during the off-drug follow-up period.
October 29th 2024
Shionogi’s ensitrelvir demonstrated reduction of symptoms in phase 3 trial.
October 24th 2024
Important vaccine updates, including a second COVID-19 vaccine dose for adults 65 and older and immunocompromised individuals, a pneumococcal vaccine for adults aged 50 and older, and more.
October 11th 2024
A NIH-funded study focused on analyzing the Wuhan strain in unvaccinated patients with COVID-19. Results showed those with certain blood types seemed to fare worse significantly increasing their risk for cardiovascular events and mortality.
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer
View More
Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients
View More
Overcoming Racial Disparities in Multiple Myeloma Outcomes and Clinical Trials: How We are Moving Care Forward Today
View More
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
COVID-19 Booster Shots and the Future
Key opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.
Watch
Booster Dose of COVID-19 Vaccine Reduces Infection in Health Care Workers in Israel
January 23rd 2022Booster doses of the Pfizer-BioNTech COVID-19 vaccine were shown to provide greater protection against infection than the 2 dose primary regimen alone, according to a study of health care workers in Israel.
Read More
Communicating the Benefit of COVID-19 Booster Shots to Patients
Donald Alcendor, PhD, and Angela Rasmussen, PhD, explain how to discuss the importance of COVID-19 booster shots with patients.
Watch
Cancer Patients and COVID-19 Outcomes by Locale
January 19th 2022For already-vulnerable cancer patients, a COVID-19 diagnosis is especially concerning. A new study reveals that when it comes to disease outcomes, geographical location is not a factor—but individual cancer centers can make a difference.
Read More
World Health Leaders Discuss Long-Term Strategy for COVID-19 Vaccines and Boosters
January 19th 2022As global health leaders discuss the best long-term strategy for COVID-19 vaccines and boosters, consensus is emerging that repeated boosters of current vaccines within short intervals is not sustainable.
Read More
2 Commerce Drive
Cranbury, NJ 08512